AzTrials
AzTrials

Bariatric SurgeryNCT03758937

Comparison of Volume Controlled Ventilation and Pressure Controlled Ventilation in Laparoscopic Bariatric Surgery

A study of Bariatric Surgery, run by Antalya Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare volume controlled-ventilation (VCV) and pressure-controlled ventilation (PCV) in terms of pulmonary gas exchange, respiratory mechanics and arterial blood gas values in patients undergoing laparoscopic bariatric surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Bariatric Surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2016to 1 Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years or above,
  • ASA II patients
  • BMI > 40 kg / m2
  • No serious comorbidity.

Who cannot join

  • Unstable patients during the operation
  • The requirement for mechanical ventilation in the postoperative period.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Antalya Traning and Research Hospital

    Antalya

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Volume Controlled Ventilation and Pressure Controlled Ventilation in Terms of Respiratory Mechanics in Laparoscopic Bariatric Surgery

The purpose of this study is to compare volume controlled-ventilation (VCV) and pressure-controlled ventilation (PCV) in terms of pulmonary gas exchange, respiratory mechanics and arterial blood gas values in patients undergoing laparoscopic bariatric surgery.

Read the detailed description

Today, morbid obesity has become a global problem. It is not clear which mechanical ventilation mode will be used in bariatric surgery, which is one of the treatment options of these patients. VCV is the most commonly used mode to ventilate anesthetized patients. However, especially in obese patients, high airway pressures and hypoxia may occur due to increased intrapulmonary shunts. Therefore, we aimed to investigate the potential of PCV strategy to improve pulmonary gas exchange, respiratory mechanics and arterial blood gas values according to VCV in patients undergoing bariatric surgery.

Being tested
volume-controlled ventilation, pressure-controlled ventilation
Keywords
bariatric surgery, volume-controlled ventilation, pressure-controlled ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • volume-controlled ventilationProcedure or surgery

  • pressure-controlled ventilationProcedure or surgery

Study groups in NCT03758937
Study groupRoleWhat they receive
volume-controlled ventilation groupActive comparatorDuring the operation, necessary interventions were made by following the algorithm. Hemodynamic and mechanical ventilation parameters of patients were recorded 5 minutes after induction, 30 minutes after pneumoperitoneum and at the end of surgery and were performed arterial blood gas analysis.
Receives: Procedure: volume-controlled ventilation
pressure-controlled ventilation groupActive comparatorDuring the operation, necessary interventions were made by following the algorithm. Hemodynamic and mechanical ventilation parameters of patients were recorded 5 minutes after induction, 30 minutes after pneumoperitoneum and at the end of surgery and were performed arterial blood gas analysis.
Receives: Procedure: pressure-controlled ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Partial oxygen pressure

    Assessed 5 minutes after induction by using arterial blood gas analysis.

    Measured: 5 minutes after induction

  2. Partial oxygen pressure

    Assessed 30 minutes after pneumoperitoneum by using arterial blood gas

    Measured: 30 minutes after pneumoperitoneum

  3. Partial oxygen pressure

    Assessed through surgery completion, an average of 90 minutes by using arterial blood gas

    Measured: through surgery completion, an average of 90 minutes

Secondary outcomes (6)
  1. Partial carbon dioxide pressure

    Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using arterial blood gas analysis.

    Measured: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes

  2. Partial carbon dioxide pressure - end-tidal carbon dioxide pressure

    Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using arterial blood gas analysis and end-tidal monitor.

    Measured: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes

  3. Peak airway pressure

    Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using the patient monitor.

    Measured: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes

  4. Dynamic compliance

    Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using formula (Tidal volume/peak airway pressure - Positive end-expiratory pressure)

    Measured: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes

  5. Inspired oxygen pressure / Fractional oxygen ratio

    Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes

    Measured: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes

  6. Alveolar-arterial oxygen gradient pressure

    Assessed 5 minutes after induction, 30 minutes after pneumoperitoneum and through surgery completion, an average of 90 minutes by using formula (D(A-a) O2).

    Measured: 5 minutes after induction, 30 minutes after pneumoperitoneum, through surgery completion, an average of 90 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2018
  2. Study start1 Apr 2016
  3. Primary completion1 Apr 2017
  4. Study completion1 Aug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03758937
Sponsor's protocol ID
AntalyaTRH31
Status last verified
Nov 2018
First submitted
27 Nov 2018
Last updated
29 Nov 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study of Bariatric Surgery, run by Antalya Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Partial oxygen pressure (time frame: 5 minutes after induction). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in